These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20933589)

  • 1. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement.
    Mehanna MM; Motawaa AM; Samaha MW
    Int J Pharm; 2010 Dec; 402(1-2):78-88. PubMed ID: 20933589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N; Katare OP; Singh B
    Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X; Liu X; Gan L; Zhou C; Mo J
    Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407.
    Vyas V; Sancheti P; Karekar P; Shah M; Pore Y
    Acta Pharm; 2009 Dec; 59(4):453-61. PubMed ID: 19919934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.
    Chen Y; Zhang GG; Neilly J; Marsh K; Mawhinney D; Sanzgiri YD
    Int J Pharm; 2004 Nov; 286(1-2):69-80. PubMed ID: 15501003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
    Mallick S; Sahu A; Pal K
    Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions.
    Ali W; Williams AC; Rawlinson CF
    Int J Pharm; 2010 May; 391(1-2):162-8. PubMed ID: 20214957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH; Bandari S; Jukanti R; Veerareddy PR
    Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
    Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
    Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.